Cassava Sciences to Present at H.C. Wainwright’s 22nd Annual Global Investment Conference
September 09 2020 - 7:15AM
Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage
biotechnology company focused on Alzheimer’s disease, announced
today that management will present a corporate overview at H.C.
Wainwright’s 22nd Annual Global Investment Conference.
Event details follow: |
Date: |
Tuesday,
September 15th |
Time: |
2:30 p.m. Eastern Time |
Webcast: |
https://www.CassavaSciences.com/company-presentations |
Cassava Sciences’ virtual public presentation
can be followed live via webcast. It will also be available
for replay for 90 days following the conference on
CassavaSciences.com in the ‘Investors’ section.
About Alzheimer's
Disease Alzheimer’s disease is a progressive brain
disorder that destroys memory and thinking skills. Currently, there
are no drug therapies to halt Alzheimer’s disease, much less
reverse its course. In the U.S. alone, approximately 5.8 million
people are currently living with Alzheimer’s disease, and
approximately 487,000 people age 65 or older developed Alzheimer’s
in 2019.1 The number of people living with Alzheimer’s disease is
expected to grow dramatically in the years ahead, resulting in a
growing social and economic burden.2
About Cassava Sciences,
Inc.Cassava Sciences’ mission is to discover
and develop innovations for chronic, neurodegenerative
conditions. Over the past 10 years, Cassava Sciences has combined
state-of-the-art technology with new insights in neurobiology to
develop novel solutions for Alzheimer’s disease. Cassava Sciences
owns worldwide development and commercial rights to its research
programs in Alzheimer’s disease, and related technologies, without
royalty obligations to any third-party.
For More Information
Contact:Eric Schoen, Chief Financial OfficerCassava
Sciences, Inc.eschoen@CassavaSciences.com(512) 501-2450
1, 2 Source: Alzheimer’s Association. 2019 Alzheimer’s Disease
Facts and Figures. Available online at:
https://www.alz.org/media/documents/alzheimers-facts-and-figures-2019-r.pdf
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Apr 2024 to May 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From May 2023 to May 2024